183 related articles for article (PubMed ID: 11350542)
41. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
[TBL] [Abstract][Full Text] [Related]
42. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].
Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P
Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432
[TBL] [Abstract][Full Text] [Related]
43. The pathology of hepatic iron overload: a free radical--mediated process?
Bacon BR; Britton RS
Hepatology; 1990 Jan; 11(1):127-37. PubMed ID: 2153094
[No Abstract] [Full Text] [Related]
44. Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience.
Restivo Pantalone G; Renda D; Valenza F; D'Amato F; Vitrano A; Cassarà F; Rigano P; Di Salvo V; Giangreco A; Bevacqua E; Maggio A
Br J Haematol; 2010 Jul; 150(2):245-7. PubMed ID: 20433678
[No Abstract] [Full Text] [Related]
45. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
[TBL] [Abstract][Full Text] [Related]
46. Protective altruistic phlebotomy: hereditary haemochromatosis presenting as hepatocellular carcinoma in a non-cirrhotic 83-year-old man.
Ooka K; Onyiuke I; Zhang X; Taddei TH
BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27591041
[TBL] [Abstract][Full Text] [Related]
47. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.
Chapoutot C; Esslimani M; Joomaye Z; Ramos J; Perney P; Laurent C; Fabbro-Peray P; Larrey D; Domergue J; Blanc F
Gut; 2000 May; 46(5):711-4. PubMed ID: 10764717
[TBL] [Abstract][Full Text] [Related]
48. [Development of hemochromatoses].
Bercovici JP; Leuzinger D
Nouv Presse Med; 1975 Sep; 4(31):2257-8. PubMed ID: 52145
[No Abstract] [Full Text] [Related]
49. Hepatocellular carcinoma arising in non-cirrhotic haemochromatosis.
Thompson NP; Stansby G; Jarmulowicz M; Hobbs KE; McIntyre N
HPB Surg; 1995 Jun; 8(3):163-6. PubMed ID: 7547618
[TBL] [Abstract][Full Text] [Related]
50. Relationship between hepatocellular carcinoma and cirrhosis.
Kew MC; Popper H
Semin Liver Dis; 1984 May; 4(2):136-46. PubMed ID: 6087459
[TBL] [Abstract][Full Text] [Related]
51. Iron, HCV, and liver cancer: hard metal setting the pace?
Mueller S; Afdhal NH; Schuppan D
Gastroenterology; 2006 Jun; 130(7):2229-34. PubMed ID: 16762645
[No Abstract] [Full Text] [Related]
52. Iron at the Interface of Hepatocellular Carcinoma.
Paganoni R; Lechel A; Vujic Spasic M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921027
[TBL] [Abstract][Full Text] [Related]
53. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
54. Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis.
Ünlüsoy Aksu A; Caleffi A; Pietrangelo A; Sari S; Eğritaş Gürkan Ö; Demirtaş Z; Yilmaz G; Dalgiç B
J Pediatr Hematol Oncol; 2017 Aug; 39(6):466-469. PubMed ID: 28067690
[TBL] [Abstract][Full Text] [Related]
55. The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.
Funakoshi N; Chaze I; Alary AS; Tachon G; Cunat S; Giansily-Blaizot M; Bismuth M; Larrey D; Pageaux GP; Schved JF; Donnadieu-Rigole H; Blanc P; Aguilar-Martinez P
Liver Int; 2016 May; 36(5):746-54. PubMed ID: 26474245
[TBL] [Abstract][Full Text] [Related]
56. Hepatoma in hemochromatosis.
Seshadri MS; Dayal AK; Bhaktaviziam A
J Assoc Physicians India; 1982 May; 30(5):333-5. PubMed ID: 6302071
[No Abstract] [Full Text] [Related]
57. Liver cancer and alcohol.
Grewal P; Viswanathen VA
Clin Liver Dis; 2012 Nov; 16(4):839-50. PubMed ID: 23101985
[TBL] [Abstract][Full Text] [Related]
58. Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection.
Chung JW; Shin E; Kim H; Han HS; Cho JY; Choi YR; Hong S; Jang ES; Kim JW; Jeong SH
Liver Int; 2018 May; 38(5):903-914. PubMed ID: 29105340
[TBL] [Abstract][Full Text] [Related]
59. [Hepatoma as a complication of hemochromatosis].
Deslypere JP; Verdonk G; Devos M; van Kerkvoorde L
Ned Tijdschr Geneeskd; 1983 Oct; 127(42):1905-8. PubMed ID: 6316171
[No Abstract] [Full Text] [Related]
60. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
